U.S. markets closed
  • S&P Futures

    3,840.25
    -2.25 (-0.06%)
     
  • Dow Futures

    30,791.00
    -51.00 (-0.17%)
     
  • Nasdaq Futures

    13,555.25
    +69.75 (+0.52%)
     
  • Russell 2000 Futures

    2,137.50
    -8.30 (-0.39%)
     
  • Crude Oil

    52.84
    +0.23 (+0.44%)
     
  • Gold

    1,845.30
    -5.60 (-0.30%)
     
  • Silver

    25.36
    -0.17 (-0.68%)
     
  • EUR/USD

    1.2161
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.0400
    0.0000 (0.00%)
     
  • Vix

    23.02
    -0.17 (-0.73%)
     
  • GBP/USD

    1.3731
    -0.0001 (-0.00%)
     
  • USD/JPY

    103.7400
    +0.1130 (+0.11%)
     
  • BTC-USD

    31,817.00
    -636.22 (-1.96%)
     
  • CMC Crypto 200

    640.65
    -6.68 (-1.03%)
     
  • FTSE 100

    6,654.01
    +15.16 (+0.23%)
     
  • Nikkei 225

    28,596.06
    +49.88 (+0.17%)
     

Penumbra, Inc. Investors: Company Investigated by the Portnoy Law Firm

Portnoy Law
·2 min read

Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, Jan. 04, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Penumbra, Inc. ("Penumbra" or the "Company") (NYSE: PEN) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

On November 10, 2020, released research report on Penumbra was released by Quintessential Capital Management entitled “Penumbra and its ‘Killer Catheter’: A tale of corporate greed and seemingly blatant disregard for patients’ lives[.]”

On December 8, 2020, a follow-up research report was released by Quintessential Capital Management entitled “Is Penumbra’s core scientific research authored by a fake person?: The incredible story of Penumbra’s Dr. Antik Bose[.]” It was alleged in this follow-up report that some of the Penumbra’s scientific research pieces appear to have been incorrectly attributed or even authored by a fake individual. On December 8, 2020, Penumbra’s share price fell $19.95 per share on this news, or almost 9%, to close at $204.07 per share.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising